Diabetes

Top Story

Bone loss remains elevated 5 years after RYGB vs. sleeve gastrectomy

Bone loss remains elevated 5 years after RYGB vs. sleeve gastrectomy
November 21, 2017

Adults with uncontrolled type 2 diabetes and obesity treated with Roux-en-Y gastric bypass surgery vs. sleeve gastrectomy or intensive medical therapy had elevated bone turnover markers 5 years later, study data show.

Sangeeta Kashyap, MD, of the department of endocrinology, diabetes and metabolism at Cleveland Clinic, and colleagues evaluated data from the STAMPEDE trial on 95 adults (mean age, 48.5 years) with uncontrolled type 2 diabetes and obesity (mean BMI, 36.5 kg/m2) randomly assigned to intensive medical therapy (n = 25), Roux-en-Y gastric bypass (RYGB; n = 37) or sleeve gastrectomy (n = 33) to determine the 5-year outcomes on bone turnover.

In the Journals Plus

Oral insulin pill ineffective for delaying, preventing type 1 diabetes progression

November 21, 2017
The risk for type 1 diabetes development was not decreased in autoantibody-positive relatives of patients with type 1 diabetes randomly assigned to oral insulin, and…
In the Journals Plus

Endocrine Society issues guidance for CGM trend arrow data

November 20, 2017
Researchers with the Endocrine Society developed two guidelines for pediatric and adult patients using the Dexcom G5 mobile continuous glucose monitor system that…

AACE, Endocrine Society Call for insulin affordability initiatives

November 20, 2017
The American Association of Clinical Endocrinologists and the Endocrine Society called on the American Medical Association to address the rising cost of insulin and the…
More Headlines »